Results 131 to 140 of about 39,460 (147)

EXPERIENCE IN 1,000 LIVER-TRANSPLANTS UNDER CYCLOSPORINE-STEROID THERAPY - A SURVIVAL REPORT [PDF]

open access: yes, 1988
ESQUIVEL, CO   +11 more
core  

Tumors of the liver [PDF]

open access: yes, 1995
Iwatsuki, S, Starzl, TE
core  

Tacrolimus (FK506) and therapy of human autoimmune disorders [PDF]

open access: yes, 1996
Abu-Elmagd, K   +8 more
core  

Pediatric liver transplantation with cyclosporine and steroids [PDF]

open access: yes, 1984
Gartner, JC   +6 more
core  

Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis

Gut, 2021
Objective Multiple clinical similarities exist between IgG4-related sclerosing cholangitis (IgG4-SC) and primary sclerosing cholangitis (PSC), and while gut dysbiosis has been extensively studied in PSC, the role of the gut microbiota in IgG4-SC remains ...
Qiaoyan Liu   +22 more
semanticscholar   +1 more source

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium

Alimentary Pharmacology and Therapeutics
Data on oral vancomycin for primary sclerosing cholangitis (PSC)‐associated inflammatory bowel disease (IBD) are limited.
A. Ricciuto   +37 more
semanticscholar   +1 more source

Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis

Gut, 2019
Objective There is a striking association between human cholestatic liver disease (CLD) and inflammatory bowel disease. However, the functional implications for intestinal microbiota and inflammasome-mediated innate immune response in CLD remain elusive.
L. Liao   +21 more
semanticscholar   +1 more source

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.

American Journal of Gastroenterology, 2019
BACKGROUND Primary sclerosing cholangitis (PSC) is a cholestatic liver disease with no effective medical therapies. A perturbation of the gut microbiota has been described in association with PSC, and fecal microbiota transplantation (FMT) has been ...
J. Allegretti   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy